Latest Financials News

OFX Group Limited posted a 3.4% drop in revenue for FY25, with profits falling over 18%, while continuing its active share buy-back strategy.

Kogan.com Ltd reports robust sales and profit growth for the first four months of 2025, powered by strong marketing investment, while its subsidiary Mighty Ape faces technical setbacks but shows early signs of recovery.

Sayona Mining reports solid FY25 operational gains and outlines strategic merger progress with Piedmont Lithium, positioning itself as a leading North American lithium producer amid a recovering market.

Avecho Biotechnology has expanded its pivotal Phase III clinical trial for a CBD insomnia treatment by adding new recruitment sites and partnering with pharmaceutical giant Sandoz to boost patient enrolment and regulatory progress.

FFI Holdings Limited has announced a pro-rata non-renounceable entitlement offer priced at $3.50 per share, aiming to raise approximately $11 million to support its food manufacturing growth and property investments. The offer closes on 17 June 2025 and is open to eligible shareholders in Australia and New Zealand.

Earlypay Limited has lowered its FY25 earnings guidance due to weaker-than-expected invoice finance usage, while signaling ongoing talks about a potential change of control.

Infinity Lithium Corporation has withdrawn from Spain’s PERTE VEC IIa capital funding program, opting to return nearly €20 million due to prolonged permitting and regulatory hurdles.

Worley Limited has reaffirmed its FY25 financial outlook, targeting low double-digit EBITA growth and margins between 8-8.5%, supported by a robust $9.4 billion bookings pipeline and a strategic operational reorganisation.

Visionflex Group has landed a significant contract with BHP to deploy its telehealth technology across 13 remote medical centres and a HEMS aircraft in Western Australia, aiming to revolutionize healthcare delivery for mining workers.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.

Brazilian Rare Earths Limited has secured a strategic partnership with SENAI CIMATEC to co-develop a rare earths laboratory and pilot plant in Bahia, Brazil, backed by significant funding and aimed at advancing processing capabilities ahead of production.